Guidelines updated for atrial fibrillation ablation at HRS 2017. Boston Scientific's Rhythmia mapping system
Feature | Atrial Fibrillation | May 15, 2017

May 15, 2017 – The Heart Rhythm Society (HRS) in joint partnership with several other electrophysiology societies...

Race, Gender and Socioeconomic Factors Impact PCI Outcomes, PLATINUM Diversity study, SCAI 2017
News | Cath Lab | May 15, 2017

May 15, 2017 — A first-of-its-kind study discovered that women and minorities who underwent a...

HRS released a consensus statement on MRI for patients with cardiac implantable electronic devices
Feature | May 15, 2017

May 15, 2017 — The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement in the United States...

Analysis Looks at Role Type of Valve Plays in Patient Outcomes Post-TAVR
News | Heart Valve Technology | May 15, 2017

May 15, 2017 — For patients who undergo...

Day of the Week PCI-Related Hospitalization Occurs Determines Likelihood of Survival, SCAI 2017
News | Cath Lab | May 15, 2017

May 15, 2017 — In a large-scale analysis of ...

Percepta, Serena, Solara CRT-P devices with quatripolar leads
Technology | Leads Implantable Devices | May 15, 2017

May 15, 2017 – The U.S. Food and Drug Administration (FDA) has granted market clearance Medtronic’s portfolio of...

Study Reveals Low Adoption of IAEA Recommendations for Reduced Nuclear Cardiology Radiation Exposure
News | Radiation Dose Management | May 12, 2017

May 12, 2017 — A study in 65 countries has revealed low adoption of International Atomic Energy Agency (IAEA)...

First Pennsylvania Patient Treated in LEADERS FREE II Trial of BioFreedom Drug-Coated Stent
News | Stents Drug Eluting | May 12, 2017

May 12, 2017 — PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania in a trial...

Stem Cell Therapy Holds Promise for Treating Most Severe Cases of Angina
News | Stem Cell Therapies | May 12, 2017

May 12, 2017 — An analysis of data from the entire development program consisting of three trials assessing the...

WiSE CRT System is a wireless cardiac resynchonization therapy device with no lead wires

The WiSE CRT System uses a tiny implant in the left ventricle to synchronize the heart, overcoming limitations of traditional Cardiac Resynchronization Therapy (CRT) in heart failure patients.

News | Heart Failure | May 12, 2017

May 12, 2017 – New study proves safety of novel, wireless pacing system, WiSE CRT (Wireless Stimulation...

anticoagulants increase dementia risks
Feature | Antiplatelet and Anticoagulation Therapies | May 12, 2017

May 12, 2017 – A new study found that dementia rates increase with delays in starting anticoagulation treatment for...

Analysis Shows Increased Risk of Early Stroke with New-Onset Atrial Fibrillation Post-TAVR, SCAI 2017 late-breaking clinical trial
News | Stroke | May 12, 2017

May 12, 2017 — More than one-third of patients undergoing...

Biotronik Announces FDA Approval of MultiPole Pacing
Technology | Cardiac Resynchronization Therapy Devices (CRT) | May 11, 2017

May 11, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval of the company's MultiPole...

Apple Watch used for tracking patient arrhythmias using an artificial intelligence-based algorithm

Researchers are using the Apple Watch heart rate monitor app to track patient arrhythmias using an artificial intelligence-based algorithm. 

Feature | Wearable Sensors | May 11, 2017

May 11, 2017 — A new study shows that the Apple Watch's heart rate sensor, when paired with an artificial...

Overlay Init